Market Research Logo

Global Hemostasis Analyzers Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Hemostasis Analyzers Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Hemostasis is the study of the methods involved in blood clotting (coagulation). Hematology analyzers, also known as coagulation analyzers, are devices supporting in treatment of patients with bleeding disorders; those with substitution heart valves and patients who are at high risk of bleeding during surgical procedures. Growing demand for fast and exact results is the driving force for companies to build up new system capabilities and modern technologies in their hematology analyzers. The global Hemostasis analyzers market is projected to growabout US$ 4500 million with a CAGR of 9.7 % during 2016-2022. A number of factors such as the expansion of high-throughput hemostasis analyzers, growing acceptance of automated hemostasis instruments by diagnostic laboratories, advancements in technology and developments of high sensitivity point-of-care hemostasis testing are pushing the growth of the global hemostasis analyzers market. The biggest challenge for the vendors is the need to focus on customer concerns and demands along with instruments provision with higher effectiveness, throughput, accuracy and improved productivity at lower cost.

Segmentation of the global hemostasis analyzers market is done into product type, type of test, technology, and user and geography. Segmentation by product type is done on the basis of clinical laboratory analyzers, consumables, and hemostasis analyzers point-of-care testing. Hemostasis analyzers sub segment of clinical laboratory analyzers is projected to observe attractive growth in the future years owing to rising demand for automated hemostasis analyzers in health diagnosis. On the basis of test type market is segmented into D dimer testing kits, fibrinogen testing kits prothrombin time testing kits, activated clotting time testing kits, and other testing kits. On the basis of technology market is segmented into optical, electrochemical, mechanical and other technology. Mechanical hemostasis analyzers are projected to observe considerable growth in the market share, largely due to sophisticated, accurate and efficient management at a lower cost. In end user market is segmented into diagnostic laboratories, research institutes, standalone hospitals and other end users. Due to the implementation of latest technology and heavy budgetary spending the medical and research institutes are expected to witness favorable growth over the forecast period.

Segmentation by geographically of the global hemostasis analyzers market is done into Asia Pacific, Europe, North America and RoW. North America region dominates the global hematology analyzers market due to the growing installed device base leading to higher support services and sales of reagents in the United States. Beckman Coulter is the market leader for hematology analyzers in the US, though company faces constant competition from Sysmex products. Rising markets of China, India and Brazil are registering significant growth due to growing population level, large healthcare expenditure by government, financial growth and improving technical abilities by these countries.

Key players operating in hemostasis analyzer market are, Alere Inc., Helena Laboratories, Horiba, Mindray, Nihon Kohden Corporation (Nihon Kohden), Roche Diagnostics, Siemens Healthcare, Sysmex Corporation and Thermo Fisher Scientific, Inc. etc. Merger & acquisitions, new product development, technological collaborations, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET SCOPE
2. MARKET OVERVIEW
2.1. GLOBAL HEMOSTASIS ANALYZER MARKET : EVOLUTION & TRANSITION
2.2. INDUSTRY STRUCTURE
2.3. MANUFACTURING PROCESS
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.6.1. R & D INVESTMENT IN HEMOSTASIS ANALYZER
2.6.2. DEMAND OF HEMOSTASIS ANALYZER ACROSS END USER INDUSTRIES
2.6.3. REVENUE OF TOP 5 MARKET PLAYERS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.7. ROI ANALYSIS
2.7.8. GAP ANALYSIS
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE
2.8.3. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS & MARKET IMPACT
3.1.1. INCREASING ADOPTION OF AUTOMATED HEMOSTASIS INSTRUMENTS BY DIAGNOSTIC LABORATORIES
3.1.2. FOCUS OF KEY PLAYERS ON THE DEVELOPMENT OF TECHNOLOGICALLY ADVANCED HEMOSTASIS ANALYZER
3.1.3. DEVELOPMENT OF HIGH THROUGHPUT HEMOSTASIS ANALYZERS
3.1.4. LARGE NUMBER OF AWARENESS CAMPAIGNS/ CONFERENCES IN DEVELOPING COUNTRIES
3.1.5. DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) HEMOSTASIS TESTING
3.2. MARKET RESTRAINTS & MARKET IMPACT
3.2.1. HIGH COST OF FULLY AUTOMATED HEMOSTASIS ANALYZERS
3.2.2. SLOW ADOPTION OF ADVANCED HEMOSTASIS INSTRUMENTS IN DEVELOPING COUNTRIES
3.3. MARKET OPPORTUNITIES
3.3.1. GROWING INCLINATION TOWARDS POINT-OF-CARE (POC) HEMOSTASIS ANALYZERS
3.3.2. RAPID GROWTH OF HEMOSTASIS MARKET IN EMERGING COUNTRIES
3.4. MARKET CHALLENGES
3.4.1. CONCERN FOR HIGHER THROUGHPUT AND ENHANCED PRODUCTIVITY AT LOWER COST.
3.4.2. STANDARDS FOR INSTRUMENTS
4. MARKET SEGMENTATION
4.1. GLOBAL HEMOSTASIS ANALYZER MARKET BY PRODUCT TYPE 2014-2022 ($ MILLION)
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. CLINICAL LABORATORY ANALYZERS 2014-2022 ($ MILLION)
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.1.5.1.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
4.1.5.1.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
4.1.5.1.3.3. PRICE ANALYSIS
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. CONSUMABLES ANALYZER 2014-2022 ($ MILLION)
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.1.5.2.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
4.1.5.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
4.1.5.2.3.3. PRICE ANALYSIS
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. POINT-OF-CARE TESTING 2014-2022 ($ MILLION)
4.1.5.3.1. APPLICATIONS
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.1.5.3.3.1. UNIT SHIPMENTS (MT) 2014-2022 ($ MILLION)
4.1.5.3.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
4.1.5.3.3.3. PRICE ANALYSIS
4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.2. GLOBAL HEMOSTASIS ANALYZER MARKET BY TEST TYPE 2014-2022 ($ MILLION)
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. PROTHROMBIN TIME (PT/INR) TESTING KITS 2014-2022 ($ MILLION)
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.1.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS 2014-2022 ($ MILLION)
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.2.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. D DIMER TESTING KITS 2014-2022 ($ MILLION)
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.3.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. FIBRINOGEN TESTING KITS 2014-2022 ($ MILLION)
4.2.5.4.1. APPLICATIONS
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.4.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. OTHERS TESTING KITS TESTING KITS 2014-2022 ($ MILLION)
4.2.5.5.1. APPLICATIONS
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.2.5.5.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
4.3. GLOBAL HEMOSTASIS ANALYZER MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. MECHANICAL TECHNOLOGIES 2014-2022 ($ MILLION)
4.3.5.1.1. APPLICATIONS
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.1.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. OPTICAL TECHNOLOGIES 2014-2022 ($ MILLION)
4.3.5.2.1. APPLICATIONS
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.2.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. ELECTROCHEMICAL TECHNOLOGIES 2014-2022 ($ MILLION)
4.3.5.3.1. APPLICATIONS
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.3.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. OTHERS TECHNOLOGIES 2014-2022 ($ MILLION)
4.3.5.4.1. APPLICATIONS
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.3.5.4.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. KEY CONCLUSIONS
4.4. GLOBAL HEMOSTASIS ANALYZER MARKET BY END USER 2014-2022 ($ MILLION)
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION
4.4.5.1. RESEARCH INSTITUTES 2014-2022 ($ MILLION)
4.4.5.1.1. APPLICATIONS
4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.4.5.1.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.1.5. KEY CONCLUSIONS
4.4.5.2. DIAGNOSTIC LABORATORIES 2014-2022 ($ MILLION)
4.4.5.2.1. APPLICATIONS
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.4.5.2.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.2.5. KEY CONCLUSIONS
4.4.5.3. STANDALONE HOSPITALS 2014-2022 ($ MILLION)
4.4.5.3.1. APPLICATIONS
4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.4.5.3.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.4.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.3.5. KEY CONCLUSIONS
4.4.5.4. OTHER END USERS 2014-2022 ($ MILLION)
4.4.5.4.1. APPLICATIONS
4.4.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
4.4.5.4.3.1. MARKET REVENUES 2014-2022 ($ MILLION)
4.4.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.4.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF M&A
5.1.2. LIST OF JV
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS – DASHBOARD
6. GLOBAL HEMOSTASIS ANALYZER MARKET BY REGION (REVENUE ANALYSIS), 2014-2022 ($ MILLION)
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.1.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.1.2.1.3. PRICE ANALYSIS
6.4.1.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.5. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.1.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.1.2.2.3. PRICE ANALYSIS
6.4.1.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.5. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.1.3. PRICE ANALYSIS
6.4.2.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.5. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.2.3. PRICE ANALYSIS
6.4.2.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.5. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.3.3. PRICE ANALYSIS
6.4.2.2.3.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.5. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.4.3. PRICE ANALYSIS
6.4.2.2.4.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.5. KEY CONCLUSIONS
6.4.2.2.5. ITALY
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.5.3. PRICE ANALYSIS
6.4.2.2.5.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.5. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.2.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.2.2.6.3. PRICE ANALYSIS
6.4.2.2.6.4. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.5. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.1.3. PRICE ANALYSIS
6.4.3.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.5. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.2.3. PRICE ANALYSIS
6.4.3.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.5. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.3.3. PRICE ANALYSIS
6.4.3.2.3.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.5. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.4.3. PRICE ANALYSIS
6.4.3.2.4.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.5. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.5.3. PRICE ANALYSIS
6.4.3.2.5.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.5. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.3.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.3.2.6.3. PRICE ANALYSIS
6.4.3.2.6.4. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.5. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.4.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.4.2.1.3. PRICE ANALYSIS
6.4.4.2.1.4. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.5. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
6.4.4.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
6.4.4.2.2.3. PRICE ANALYSIS
6.4.4.2.2.4. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.5. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ALERE INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.2. BECKMAN COULTER
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.3. BECTON DICKINSON
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.4. DIAGNOSTICA STAGO INC.
7.4.1. . OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.5. HELENA LABORATORIES
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.6. HORIBA
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.7. INSTRUMENTATION LABORATORY WERFEN GROUP
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.8. INTERNATIONAL TECHNIDYNE CORPORATION
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.9. MINDRAY
7.9.1. . OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.10. NIHON KOHDEN CORPORATION (NIHON KOHDEN)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.11. ROCHE DIAGNOSTICS
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6.
7.12. SIEMENS HEALTHCARE
7.12.1. . OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.13. SYSMEX CORPORATION
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.14. THERMO FISHER SCIENTIFIC, INC.
7.14.1. . OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.15. TRANSASIA BIO MEDICAL LTD.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
LIST OF TABLES
GLOBAL HEMOSTASIS ANALYZER MARKET BY PRODUCT TYPE ($ MILLION)
GLOBAL HEMOSTASIS CLINICAL LABORATORY ANALYZERS MARKET BY GEOGRAPHY - ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER CONSUMABLES MARKET BY GEOGRAPHY - ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER FOR POINT-OF-CARE TESTING MARKET BY GEOGRAPHY - ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER MARKET BY TEST TYPE ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER PROTHROMBIN TIME (PT/INR) TESTING KITS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER D DIMER TESTING KITS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER FIBRINOGEN TESTING KITS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OTHERS TESTING KITS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER MARKET BY TECHNOLOGY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER MECHANICAL MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OPTICAL MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER ELECTROCHEMICAL MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OTHERS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER MARKET BY END USER ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER RESEARCH INSTITUTES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER DIAGNOSTIC LABORATORIES MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER STANDALONE HOSPITALS MARKET BY GEOGRAPHY ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OTHER END USERS MARKET BY GEOGRAPHY ($ MILLION)
NORTH AMERICA HEMOSTASIS ANALYZER MARKET ($ MILLION)
EUROPE HEMOSTASIS ANALYZER MARKET ($ MILLION)
ASIA PACIFIC HEMOSTASIS ANALYZER MARKET ($ MILLION)
REST OF THE WORLD HEMOSTASIS ANALYZER MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL HEMOSTASIS ANALYZER CLINICAL LABORATORY ANALYZERS MARKET - ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER CONSUMABLES MARKET - ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER FOR POINT-OF-CARE TESTING MARKET - ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER PROTHROMBIN TIME (PT/INR) TESTING KITS MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER D DIMER TESTING KITS MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER FIBRINOGEN TESTING KITS MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OTHERS TESTING KITS MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER MECHANICAL MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OPTICAL MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER ELECTROCHEMICAL MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OTHERS MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER RESEARCH INSTITUTES MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER DIAGNOSTIC LABORATORIES MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER STANDALONE HOSPITALS MARKET ($ MILLION)
GLOBAL HEMOSTASIS ANALYZER OTHER END USERS MARKET ($ MILLION)
NORTH AMERICA HEMOSTASIS ANALYZER MARKET ($ MILLION)
UNITED STATES (U.S.) HEMOSTASIS ANALYZER MARKET ($ MILLION)
CANADA HEMOSTASIS ANALYZER MARKET ($ MILLION))
EUROPE HEMOSTASIS ANALYZER MARKET ($ MILLION)
UNITED KINGDOM (UK) HEMOSTASIS ANALYZER MARKET ($ MILLION)
FRANCE HEMOSTASIS ANALYZER MARKET ($ MILLION)
GERMANY HEMOSTASIS ANALYZER MARKET ($ MILLION)
SPAIN HEMOSTASIS ANALYZER MARKET ($ MILLION)
ITALY HEMOSTASIS ANALYZER MARKET ($ MILLION)
ROE HEMOSTASIS ANALYZER MARKET ($ MILLION)
ASIA PACIFIC HEMOSTASIS ANALYZER MARKET ($ MILLION)
INDIA HEMOSTASIS ANALYZER MARKET ($ MILLION)
CHINA HEMOSTASIS ANALYZER MARKET ($ MILLION)
JAPAN HEMOSTASIS ANALYZER MARKET ($ MILLION)
KOREA HEMOSTASIS ANALYZER MARKET ($ MILLION)
AUSTRALIA HEMOSTASIS ANALYZER MARKET ($ MILLION)
ROAPAC HEMOSTASIS ANALYZER MARKET ($ MILLION)
REST OF THE WORLD HEMOSTASIS ANALYZER MARKET ($ MILLION)
LATIN AMERICA HEMOSTASIS ANALYZER MARKET ($ MILLION)
MENA HEMOSTASIS ANALYZER MARKET ($ MILLION)
AFRICA HEMOSTASIS ANALYZER MARKET 2014-2022 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report